Functional interaction between tumor suppressor menin and activator of S-phase kinase

Robert W Schnepp1, Zhaoyuan Hou, Haoren Wang

  • 1Abramson Family Cancer Research Institute, Department of Cancer Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

Cancer Research
|September 18, 2004
PubMed

Insights

Menin, a tumor suppressor, is essential for regulating cell proliferation. Menin interacts with activator of S-phase kinase (ASK) to inhibit cell growth, demonstrating a novel link in cell cycle control.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Multiple endocrine neoplasia type I (MEN1) is a hereditary syndrome involving tumors in multiple endocrine organs.
  • The Men1 gene encodes the tumor suppressor protein menin, which is implicated in tumor development.
  • The precise role of menin in regulating cell proliferation and its mechanism of action remain unclear.

Purpose of the Study:

  • To investigate the role of menin in cell proliferation control.
  • To elucidate the molecular mechanism by which menin regulates cell proliferation.
  • To identify potential interactions between menin and key cell cycle regulators.

Main Methods:

  • Gene targeting to create menin-null cells and complementation studies.
  • Analysis of cell proliferation rates in response to menin manipulation.
  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • In vitro kinase assays and cell-based proliferation assays.

Main Results:

  • Targeted disruption of the Men1 gene resulted in enhanced cell proliferation.
  • Complementation of menin-null cells with menin reduced cell proliferation.
  • Menin was found to interact with activator of S-phase kinase (ASK), a critical component of the Cdc7/ASK complex.
  • Wild-type menin, but not disease-related mutants lacking ASK interaction, effectively repressed ASK-induced cell proliferation.

Conclusions:

  • Menin plays an essential role in the repression of cell proliferation.
  • Menin's interaction with ASK is crucial for its tumor-suppressive function.
  • These findings establish a functional link between menin and ASK in regulating cell proliferation and provide insights into MEN1 pathogenesis.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...